• OPEN AN ACCOUNT
Indian Indices
Sensex
84,961.14 -102.20
( -0.12%)
Global Indices
Nasdaq
49,481.66 483.47
(0.99%)
Dow Jones
6,965.42 42.37
(0.61%)
Hang Seng
51,924.52 -593.56
(-1.13%)
Nikkei 225
10,039.39 -83.34
(-0.82%)
Forex
USD-INR
90.21 0.17
(0.19%)
EUR-INR
105.52 0.01
(0.01%)
GBP-INR
121.54 0.38
(0.31%)
JPY-INR
0.58 0.00
(0.26%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
37.0210703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
245.58
289.23
EPS(TTM)
Face Value()
Div & Yield %
0.33
10
0
 
( Cr)
ParticularsSep 2025 ( Cr)Jun 2025 ( Cr)Mar 2025 ( Cr)
Gross Sales32.9729.1830.52
Other Operating Income0.000.000.00
Other Income 1.210.670.72
Total Income34.1929.8431.24
Total Expenditure 36.1225.7927.11
PBIDT-1.944.064.13
Interest 0.790.850.52
PBDT-2.733.203.61
Depreciation2.072.031.34
Tax0.180.310.62
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.350.050.35
Reported Profit After Tax-3.630.811.31
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-3.630.811.31
EPS (Unit Curr.)-1.020.220.36
EPS (Adj) (Unit Curr.)-1.020.220.36
Calculated EPS (Unit Curr.)-1.020.230.37
Calculated EPS (Adj) (Unit Curr.)-1.020.230.37
Calculated EPS (Ann.) (Unit Curr.)-4.060.911.46
Calculated EPS (Adj) (Ann.) (Unit Curr.)-4.060.911.46
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity35.6935.6935.69
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-5.8813.9113.53
PBDTM(%)-8.2810.9711.83
PATM(%)-11.012.784.29